TipRanks
Go Ultimate55% OFF

Comparison Results

Comparison results
NamePricePrice ChangePrice TargetSmart ScoreExpense RatioAsset Under ManagementFollow
LLYXDefiance Daily Target 2X Long LLY ETF$35.58―1.49%86.94M
NVOXDefiance Daily Target 2X Long NVO ETF$10.27―1.31%37.01M
NVOCCorgi NVO 2x Daily ETF$15.52―0.45%223.90K
IHEiShares U.S. Pharmaceuticals ETF$107.61$126.62(17.66% Upside)0.37%1.60B
FTXHFirst Trust Nasdaq Pharmaceuticals ETF$44.24$47.84(8.13% Upside)0.60%1.18B
PPHVanEck Pharmaceutical ETF$119.33$135.56(13.60% Upside)0.36%1.08B
PJPInvesco Dynamic Pharmaceuticals ETF$130.54$158.86(21.69% Upside)0.58%575.09M
XPHSPDR S&P Pharmaceuticals ETF$64.80$109.12(68.40% Upside)0.35%466.58M
NVOHNovo Nordisk A/S (B Shares) ADRhedged$22.57$23.90(5.92% Upside)0.19%3.77M
GSKHGSK plc ADRhedged$69.49$86.45(24.40% Upside)0.19%685.22K

Performance Comparison

-50%0%50%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
LLYXDefiance Daily Target 2X Long LLY ETF35.5817.3695.28%
NVOXDefiance Daily Target 2X Long NVO ETF10.27-11.25-52.28%
NVOCCorgi NVO 2x Daily ETF15.52-9.34-37.57%
IHEiShares U.S. Pharmaceuticals ETF107.6132.4743.21%
FTXHFirst Trust Nasdaq Pharmaceuticals ETF44.2414.5048.74%
PPHVanEck Pharmaceutical ETF119.3328.3431.15%
PJPInvesco Dynamic Pharmaceuticals ETF130.5434.5736.02%
XPHSPDR S&P Pharmaceuticals ETF64.8015.3431.00%
NVOHNovo Nordisk A/S (B Shares) ADRhedged22.57-3.03-11.82%
GSKHGSK plc ADRhedged69.494.847.48%

ETFs Similar to ELIL FAQ

What is the cheapest alternative to ELIL?
Among the ETFs similar to ELIL, NVOH (Novo Nordisk A/S (B Shares) ADRhedged) has the lowest expense ratio, at 0.19% a year, compared with 1.07% for ELIL.
ELIL vs. LLYX: what is the difference?
LLYX (Defiance Daily Target 2X Long LLY ETF) is the first ETF in ELIL's similar-ETF list. It has $86.94M in assets under management and a 1.49% expense ratio, against $21.93M and 1.07% for ELIL. Compare their performance, price targets and Smart Scores in the table above.